Trial · NCT03158948
Adverse events148
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 148
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 12 | 0 |
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Nangibotide 0.3 mg/kg/h | 1 | 13 | 1 |
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Nangibotide 1.0 mg/kg/h | 3 | 12 | 3 |
| other | Bronchitis | Respiratory, thoracic and mediastinal disorders | Nangibotide 3.0 mg/kg/h | 0 | 12 | 0 |
| other | Confusional State | Nervous system disorders | Placebo | 2 | 12 | 2 |
| other | Confusional State | Nervous system disorders | Nangibotide 0.3 mg/kg/h | 0 | 13 | 0 |
| other | Confusional State | Nervous system disorders | Nangibotide 1.0 mg/kg/h | 0 | 12 | 0 |
| other | Confusional State | Nervous system disorders | Nangibotide 3.0 mg/kg/h | 2 | 12 | 2 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Placebo | 1 | 12 | 1 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Nangibotide 0.3 mg/kg/h | 0 | 13 | 0 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Nangibotide 1.0 mg/kg/h | 1 | 12 | 1 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Nangibotide 3.0 mg/kg/h | 2 | 12 | 2 |
| other | Hypophosphataemia | Metabolism and nutrition disorders | Placebo | 2 | 12 | 2 |
| other | Hypophosphataemia | Metabolism and nutrition disorders | Nangibotide 0.3 mg/kg/h | 0 | 13 | 0 |
| other | Hypophosphataemia | Metabolism and nutrition disorders | Nangibotide 1.0 mg/kg/h | 0 | 12 | 0 |
| other | Hypophosphataemia | Metabolism and nutrition disorders | Nangibotide 3.0 mg/kg/h | 2 | 12 | 2 |
| other | Intra-Abdominal Fluid Collection | Gastrointestinal disorders | Placebo | 1 | 12 | 1 |
| other | Intra-Abdominal Fluid Collection | Gastrointestinal disorders | Nangibotide 0.3 mg/kg/h | 1 | 13 | 1 |
| other | Intra-Abdominal Fluid Collection | Gastrointestinal disorders | Nangibotide 1.0 mg/kg/h | 2 | 12 | 2 |
| other | Intra-Abdominal Fluid Collection | Gastrointestinal disorders | Nangibotide 3.0 mg/kg/h | 0 | 12 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03158948/events?page=2